# _embedded.samples[].characteristics.sample title[].text
Colorectal cancer tissue sample (FFPE) 235

# _embedded.samples[].characteristics.secondary description[].text
CAIRO2 arm A: capecitabine, oxaliplatin and bevacizumab Normal colon mucosa from the same patient as the tumor was used as reference in the aCGH experiments.

# _embedded.samples[].characteristics.sample title[].text
Colorectal cancer tissue sample (FFPE) 22

# _embedded.samples[].characteristics.secondary description[].text
CAIRO arm A: capecitabine first line Normal colon mucosa from the same patient as the tumor was used as reference in the aCGH experiments.

# _embedded.samples[].organization[].Name
MRC - National Insititute for Medical Research

# _embedded.samples[].characteristics.sample title[].text
Colorectal cancer tissue sample (FFPE) 176

# _embedded.samples[].characteristics.secondary description[].text
CAIRO arm B: capecitabine and irinotecan first line Normal colon mucosa from the same patient as the tumor was used as reference in the aCGH experiments.

# _embedded.samples[].characteristics.sample title[].text
Colorectal cancer tissue sample (FFPE) 127

# _embedded.samples[].characteristics.secondary description[].text
CAIRO arm B: capecitabine and irinotecan first line Normal colon mucosa from the same patient as the tumor was used as reference in the aCGH experiments.

# _embedded.samples[].characteristics.sample title[].text
Colorectal cancer tissue sample (FFPE) 118

# _embedded.samples[].characteristics.secondary description[].text
CAIRO arm B: capecitabine and irinotecan first line Normal colon mucosa from the same patient as the tumor was used as reference in the aCGH experiments.

# _embedded.samples[].characteristics.sample title[].text
Colorectal cancer tissue sample (FFPE) 3

# _embedded.samples[].characteristics.secondary description[].text
CAIRO arm B: capecitabine and irinotecan first line Normal colon mucosa from the same patient as the tumor was used as reference in the aCGH experiments.

# _embedded.samples[].characteristics.sample title[].text
Colorectal cancer tissue sample (FFPE) 43

# _embedded.samples[].characteristics.secondary description[].text
CAIRO arm B: capecitabine and irinotecan first line Normal colon mucosa from the same patient as the tumor was used as reference in the aCGH experiments.

# _embedded.samples[].characteristics.sample title[].text
Colorectal cancer tissue sample (FFPE) 216

# _embedded.samples[].characteristics.secondary description[].text
CAIRO arm A: capecitabine first line Normal colon mucosa from the same patient as the tumor was used as reference in the aCGH experiments.

# _embedded.samples[].characteristics.sample title[].text
Colorectal cancer tissue sample (FFPE) 194

# _embedded.samples[].characteristics.secondary description[].text
CAIRO arm B: capecitabine and irinotecan first line Normal colon mucosa from the same patient as the tumor was used as reference in the aCGH experiments.

# _embedded.samples[].characteristics.sample title[].text
Colorectal cancer tissue sample (FFPE) 237

# _embedded.samples[].characteristics.secondary description[].text
CAIRO2 arm A: capecitabine, oxaliplatin and bevacizumab Normal colon mucosa from the same patient as the tumor was used as reference in the aCGH experiments.

# _embedded.samples[].characteristics.sample title[].text
Colorectal cancer tissue sample (FFPE) 215

# _embedded.samples[].characteristics.secondary description[].text
CAIRO arm A: capecitabine first line Normal colon mucosa from the same patient as the tumor was used as reference in the aCGH experiments.

# _embedded.samples[].characteristics.sample title[].text
Colorectal cancer tissue sample (FFPE) 17

# _embedded.samples[].characteristics.secondary description[].text
CAIRO arm B: capecitabine and irinotecan first line Normal colon mucosa from the same patient as the tumor was used as reference in the aCGH experiments.

# _embedded.samples[].characteristics.sample title[].text
Colorectal cancer tissue sample (FFPE) 285

# _embedded.samples[].characteristics.secondary description[].text
CAIRO2 arm A: capecitabine, oxaliplatin and bevacizumab Normal colon mucosa from the same patient as the tumor was used as reference in the aCGH experiments.

# _embedded.samples[].characteristics.sample title[].text
Colorectal cancer tissue sample (FFPE) 165

# _embedded.samples[].characteristics.secondary description[].text
CAIRO arm B: capecitabine and irinotecan first line Normal colon mucosa from the same patient as the tumor was used as reference in the aCGH experiments.

# _embedded.samples[].characteristics.sample title[].text
Colorectal cancer tissue sample (FFPE) 205

# _embedded.samples[].characteristics.secondary description[].text
CAIRO arm B: capecitabine and irinotecan first line Normal colon mucosa from the same patient as the tumor was used as reference in the aCGH experiments.

# _embedded.samples[].characteristics.sample source name[].text
The CR (common reference) was a mixture of all RNA samples from this microarray study.

# _embedded.samples[].characteristics.sample title[].text
Colorectal cancer tissue sample (FFPE) 273

# _embedded.samples[].characteristics.secondary description[].text
CAIRO2 arm A: capecitabine, oxaliplatin and bevacizumab Normal colon mucosa from the same patient as the tumor was used as reference in the aCGH experiments.

# _embedded.samples[].characteristics.sample title[].text
Colorectal cancer tissue sample (FFPE) 52

# _embedded.samples[].characteristics.secondary description[].text
CAIRO arm A: capecitabine first line Normal colon mucosa from the same patient as the tumor was used as reference in the aCGH experiments.

# _embedded.samples[].characteristics.sample source name[].text
MO2-injected at 1-2 cell stage, veh-injected at 24 hpf, RNA isolated from 20 embryos at 30 hpf

# _embedded.samples[].characteristics.sample title[].text
Colorectal cancer tissue sample (FFPE) 122

# _embedded.samples[].characteristics.secondary description[].text
CAIRO arm B: capecitabine and irinotecan first line Normal colon mucosa from the same patient as the tumor was used as reference in the aCGH experiments.